INVIRASE vs LAMIVUDINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. INVIRASE and LAMIVUDINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INVIRASE	LAMIVUDINE
Rating	New	66/100
Pharmacy pays	—	$0.44 /mL
Type	RX	RX
Active ingredient	SAQUINAVIR MESYLATE	LAMIVUDINE
Manufacturer	Hoffmann La Roche	Apotex
Dosage forms	Tablet, Capsule	Tablet
Drug class	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Boxed warning	None	Boxed warning
Treats	Acquired Immunodeficiency Syndrome	Acquired Immunodeficiency Syndrome

invirase lamivudine

Rating

New

66/100

Pharmacy pays

—

$0.44 /mL

Type

Active ingredient

SAQUINAVIR MESYLATE

LAMIVUDINE

Manufacturer

Hoffmann La Roche

Apotex

Dosage forms

Tablet, Capsule

Tablet

Drug class

—

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

None

Boxed warning

Treats

Acquired Immunodeficiency Syndrome

Frequently asked questions

What is the difference between Invirase and Lamivudine?

Invirase contains Saquinavir Mesylate, while Lamivudine contains Lamivudine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.